NCT02056977

Brief Summary

The purpose of this study is to:

  • Compare PEEP level selected by individualized PEEP titration by electrical impedance tomography and PEEP level routinely used in post-operative cardiac patients with Hypoxemic Respiratory Failure;
  • Evaluate the agreement between the results of a rapid titration (total procedure duration = 5 min) versus an already validated slow titration (total procedure duration = 40 min) of the same patient, sequentially. Specifically, degree of collapse and degree of distention in each PEEP level, estimated by EIT;
  • Compare hemodynamics during the two maneuvers of PEEP titration;
  • Evaluate the efficacy of the selected PEEP (minimum PEEP preventing lung collapse less than 5%) to maintain stable levels of the following variables: arterial oxygenation, respiratory system compliance, and degree of collapse by EIT;
  • Compare these results (evolution of the three variables, along 4 hours) with the control strategy (default strategy currently used in the institution) group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 6, 2014

Completed
12 months until next milestone

Study Start

First participant enrolled

February 1, 2015

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

November 22, 2017

Status Verified

November 1, 2017

Enrollment Period

2.8 years

First QC Date

February 5, 2014

Last Update Submit

November 21, 2017

Conditions

Keywords

Acute Respiratory Distress SyndromeCardiac Surgical ProcedureMechanical VentilationPostoperative ComplicationsPositive End-Expiratory PressureLung CollapseRespiratory FailureElectrical Impedance Tomography

Outcome Measures

Primary Outcomes (1)

  • To test the agreement between the ideal PEEP determined by rapid titration versus and the ideal PEEP determined by the slow PEEP titration maneuver.

    Evaluate the agreement between the ideal PEEP determined by the rapid PEEP titration maneuver versus the ideal PEEP determined by the slow PEEP titration maneuver. The degree of collapse and overdistention at each PEEP level, as estimated by EIT, will be also compared during both procedures. Ideal PEEP is the minimum PEEP capable of keeping collapse at \< 5%.

    2 hours

Secondary Outcomes (1)

  • Stability of the selected PEEP according to the rapid titration in arterial oxygenation (SpO2, in %), respiratory system compliance (in cmH2O), and degree of collapse by EIT (in %)

    4 hours

Other Outcomes (1)

  • Comparison of the PEEP levels selected by the proposed strategy (rapid titration maneuver) and the PEEP levels used in the control group.

    4 hours

Study Arms (2)

Titration

EXPERIMENTAL

Individualized PEEP titration by EIT

Other: Titration

Control

ACTIVE COMPARATOR

PEEP stablished according to the routines at the institution (PEEP table according to the P/F ratio)

Other: control

Interventions

Individualized PEEP according to PEEP titration monitored by EIT

Also known as: Individualized PEEP
Titration
controlOTHER

PEEP selected according to a PaO2/FIO2 table as in the routines of the institution

Also known as: Control PEEP
Control

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Immediate postoperative period of myocardial revascularization and/or heart valve surgery (aortic and/or mitral)
  • Acute respiratory distress syndrome with ratio of partial pressure of arterial oxygen over fraction of inspired oxygen (PaO2:FiO2) no \>200 mmHg and bilateral pulmonary infiltrates on XRay consistent with edema, and no clinical evidence of left atrial hypertension (pulmonary capillary wedge pressure \<18 mmHg, when available).
  • Age \> 18 and \< 70 years old
  • Absence previous pulmonary disease
  • Left ventricular ejection fraction \> 35%
  • Absence of previous cardiac surgery and / or lung disease;
  • Not requiring adjusted volume expansion (pulse pressure delta \<13% or legs raising test without hemodynamic changes in cardiac index or mean arterial pressure).
  • Body mass index \< 40 kg/m2
  • Written inform consent

You may not qualify if:

  • MAP \< 70 mmHg
  • Noradrenaline \> 1 micrograms/Kg/min
  • Acute arrhythmias
  • Blooding associated to hemodynamic instability
  • Need of re-surgery and/or mechanical circulatory assistance
  • Suspicion of neurological alteration
  • Chest tube with persistent air leak

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USP Instituto do Coração

São Paulo, 05.403-010, Brazil

RECRUITING

Related Publications (1)

  • Costa EL, Amato M. Hemodynamic and respiratory changes during lung recruitment and descending optimal positive end-expiratory pressure titration with acute respiratory distress syndrome. Crit Care Med. 2007 Aug;35(8):1998-9; author reply 1999. doi: 10.1097/01.ccm.0000277060.87425.6b. No abstract available.

    PMID: 17667256BACKGROUND

MeSH Terms

Conditions

Respiratory InsufficiencyRespiratory Distress SyndromePostoperative ComplicationsPulmonary Atelectasis

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesLung DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Marcelo BP Amato

    Department of Cardio-Pulmonar, Pulmonary Division, Hospital das Clínicas, University of São Paulo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2014

First Posted

February 6, 2014

Study Start

February 1, 2015

Primary Completion

December 1, 2017

Study Completion

January 1, 2018

Last Updated

November 22, 2017

Record last verified: 2017-11

Locations